MidAtlantic Capital Management Inc. Acquires 437 Shares of CVS Health Co. (NYSE:CVS)

MidAtlantic Capital Management Inc. boosted its holdings in CVS Health Co. (NYSE:CVS) by 112.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 827 shares of the pharmacy operator’s stock after acquiring an additional 437 shares during the period. MidAtlantic Capital Management Inc.’s holdings in CVS Health were worth $37,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Integrated Advisors Network LLC raised its stake in shares of CVS Health by 0.7% during the 3rd quarter. Integrated Advisors Network LLC now owns 27,625 shares of the pharmacy operator’s stock worth $1,737,000 after purchasing an additional 200 shares during the period. Widmann Financial Services Inc. increased its holdings in CVS Health by 1.8% during the third quarter. Widmann Financial Services Inc. now owns 11,506 shares of the pharmacy operator’s stock worth $724,000 after buying an additional 200 shares during the last quarter. DT Investment Partners LLC boosted its stake in CVS Health by 7.8% in the third quarter. DT Investment Partners LLC now owns 2,777 shares of the pharmacy operator’s stock valued at $175,000 after acquiring an additional 202 shares during the last quarter. United Asset Strategies Inc. grew its position in shares of CVS Health by 2.4% during the 3rd quarter. United Asset Strategies Inc. now owns 9,217 shares of the pharmacy operator’s stock valued at $580,000 after acquiring an additional 212 shares during the period. Finally, Albert D Mason Inc. increased its stake in shares of CVS Health by 1.5% during the 3rd quarter. Albert D Mason Inc. now owns 15,425 shares of the pharmacy operator’s stock worth $970,000 after purchasing an additional 224 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on CVS. UBS Group dropped their price objective on CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a research note on Tuesday. Mizuho cut their price target on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. Cantor Fitzgerald upgraded CVS Health from a “neutral” rating to an “overweight” rating in a research note on Wednesday. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective for the company in a report on Tuesday, December 3rd. Finally, Royal Bank of Canada lowered their target price on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a report on Friday, November 15th. Five equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the stock. According to MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and an average target price of $70.28.

CVS Health Stock Performance

NYSE CVS opened at $66.35 on Friday. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The company has a fifty day moving average of $50.71 and a 200-day moving average of $55.94. The company has a market capitalization of $83.49 billion, a P/E ratio of 16.84, a P/E/G ratio of 0.60 and a beta of 0.61. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. As a group, equities research analysts predict that CVS Health Co. will post 5.14 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.01%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is presently 72.68%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.